Autism, Speech Delay & Neuro-Immune Recovery Case Study | Functional Medicine

Q: My child is non-verbal — is there any point investigating their gut?

Functional medicine does not diagnose, treat or cure autism or speech delay. It investigates the gut, immune, nutritional and methylation drivers that influence how a child's body is operating alongside their neurodevelopmental profile, and builds a protocol to support the body's own regulatory systems. In this case the work addressed yeast and bacterial overgrowth, a compromised methylation pathway, a raised heavy-metal burden and an activated neuro-immune picture. It ran alongside the child's ongoing ABA therapy, GP care and school support throughout — not instead of them. Over two and a half years her expressive language moved from a handful of single words to full sentences and back-and-forth conversation.

Q: What is the neuro-immune model of autism?

The neuro-immune model describes an over-active immune response within the central nervous system, layered on top of contributing factors such as gut dysbiosis, impaired methylation and a toxic-metal burden. In this case the working model held that the repetitive movements and hyperactivity tracked with neuro-excitation and immune activation, while the speech and comprehension delay tracked with the developmental and methylation picture. This is a clinical working model that guides which drivers are investigated and supported. It is not a diagnosis, and it does not replace neurodevelopmental assessment by a paediatric team.

Q: How many findings does a functional panel actually return? (In this case, fewer than you would think)

Fewer than the marketing implies, and that is the point. Four panels were run here — organic acids, GI-MAP stool, hair elements and a methylation panel with genomics — totalling roughly 230 markers. The organic acids panel flagged two of seventy-seven : a yeast metabolite, and a vitamin C that was effectively absent. Everything else was normal. A panel earns its cost as much by what it rules out as by what it finds, and a page listing twenty dramatic abnormalities should make you suspicious rather than impressed. Re-reading these raw reports against two and a half years of clinical notes also corrected the record in both directions — findings the notes had missed, and findings the notes had invented.

Q: What does a COMT variant mean for a child with autism?

COMT is an enzyme that clears dopamine and other catecholamines from the synapse. A double variant is associated with slower clearance, which can mean neurotransmitters linger longer — relevant to a picture of neuro-excitation, emotional meltdowns and difficulty settling. In this case the COMT variant was A/A homozygous, sitting alongside an MTRR A66G G/G homozygous variant impairing B12 recycling and a heterozygous MTHFR C677T downregulating folate metabolism, with glutathione and cysteine both measuring below range. Genetic variants are not destiny: they describe how a pathway is likely to behave under load, which informs what nutritional support that pathway may benefit from. They are common in the general population and are not diagnostic of autism.

Q: Why is folinic acid used for speech delay in autism?

Folinic acid is the active, reduced form of folate. A randomised, double-blind, placebo-controlled trial published in Molecular Psychiatry in 2018 reported improvements in verbal communication in children with autism and language impairment given high-dose folinic acid. In this case folinic acid was included from the first appointment specifically for the speech picture, alongside methyl B12 for the flagged methylation pathway, and was gradually titrated upward over the programme as her language developed. Research describes what happened across a population — it does not predict the outcome for any individual child.

Q: Why were antifungals pulsed rather than taken continuously?

Yeast and mould are highly adaptable and can become tolerant to an antifungal agent that is used continuously. Pulsing — alternating agents on a weekly cycle rather than running one without interruption — is used to reduce that adaptation. In this case arabinose, a yeast overgrowth metabolite, measured 88 against a ceiling of 56 on the organic acids test — while the stool panel detected no Candida at all, so the picture rested on the urinary marker rather than a cultured organism. A pulsed regimen alternated two different antifungal approaches on alternating weeks across a four-month course. Any antifungal work in a child should be introduced slowly and monitored, as clearing organisms too quickly can produce a temporary worsening of symptoms.

Q: Should I expect this to take months or years?

Years. Anyone promising otherwise for a developmental picture is selling something. Her mother reported increased interaction and listening within two months. Clearer speech, better eye contact and markedly reduced finger-flicking were noted at around three months. Connecting words together came at ten months. Full sentences and two-way conversation developed across the second year. The most useful signal was not the speed but the absence of a plateau — a sustained upward trajectory over two and a half years, corroborated by her school.

Q: Where does this sit next to ABA and my GP?

No. This child continued ABA therapy throughout the programme, remained under her GP, and her school remained closely involved. When her school raised concentration concerns and a possible attention-deficit picture, the clinical recommendation was to start the formal assessment process — take up the school psychiatrist's offer of a report and request a GP referral to CAMHS. Nutritional therapy sat alongside that care, investigating the gut, immune, metal and methylation questions a standard appointment has no time to ask. Diagnosis and developmental assessment remain with the medical and educational teams.

Home About Paul Conditions Testimonials Case Studies Book a Clarity Call

Story Root Causes Lab Results Timeline Protocol Outcomes Lessons Limitations FAQ BOOK NOW

Autism Spectrum Speech Delay Gut-Brain Axis Methylation Paediatric Nutrition

She Couldn't Tell Them
What She Needed.
Now She Talks Back.

A five-year-old girl with autism and severe speech delay — a handful of single words, no sentences, no way to ask for anything. Two and a half years of root-cause work later, she speaks in full sentences and holds a proper back-and-forth conversation.

Sentences

From a handful of words

2.5 yrs

Programme so far · ongoing

230+

Markers across 4 panels

Sleep

Natural onset · melatonin stopped

Developmental and behavioural changes — speech, eye contact, repetitive movements, sleep — were reported by her mother and her school, and observed at clinical follow-up. No formal developmental scoring was carried out by this clinic; that remains with her medical and educational teams. Laboratory values on this page are the actual reported results against the printed reference ranges, from four accredited laboratories.

Her Mother's Reality

"She is five. She is standing in front of you, and something is wrong, and she cannot tell you what it is. Not won't — can't. You go through the list. Hungry? Hurt? Too loud? Too bright? You are guessing at your own child. And when the guessing fails, the crying starts, and you hold her through it knowing that somewhere behind those eyes is a whole person with something to say and no way to say it. That is the part nobody outside it understands. Not the diagnosis. The silence where your daughter should be."

Client Overview

Age & Gender

Five at first appointment · seven now · Female

Diagnosis

Autism Spectrum Disorder with speech and language delay

Presenting Concerns

Effectively non-verbal — a few single words · no sentences · unable to communicate needs · repetitive movements · disrupted sleep

Programme Length

2.5 years — ongoing · Started January 2024

Care Running Alongside

ABA therapy throughout · GP · school closely involved · ADHD assessment pathway now opened

Tests Commissioned

Organic Acids · GI-MAP stool · Hair Tissue Mineral Analysis · Methylation panel with genetic variants

Starting Picture

Few words · limited eye contact · finger-flicking · emotional meltdowns · poor sleep · comprehension ahead of speech

Progress at Year 2.5

Full sentences · two-way conversation · calmer · sleeping naturally · school reporting sustained upward trajectory

Key Clinical Takeaways

1
In autism with speech delay, the gut, immune and methylation pictures are rarely separate problems. Here everything pointed one way — a single neuro-immune model: an over-active immune response in the central nervous system, layered on impaired methylation genetics, gut dysbiosis and four raised toxic metals.
2
Two symptom clusters tracked two different drivers. The repetitive movements and hyperactivity moved with neuro-excitation and immune activation — they visibly improved on antiviral work and returned when it stopped. The speech and comprehension delay moved with the developmental and methylation picture. Reading them as one problem would have produced the wrong plan.
3
The methylation genomics carried more weight than the biochemistry: COMT A/A and MTRR G/G homozygous variants plus a heterozygous MTHFR C677T — slower dopamine clearance, impaired B12 recycling, downregulated folate metabolism. Glutathione and its precursor cysteine both measured below range. Folinic acid — the active form of folate, with randomised trial evidence for verbal communication in autism — was included from the first appointment and titrated upward as her language developed.
4
Progress over two and a half years was slow, cumulative and — critically — showed no plateau. In a developmental picture, sustained trajectory is a more meaningful signal than the speed of any single change. Her school independently corroborated a year-long upward trend.
5
Re-reading the raw laboratory reports against two and a half years of working notes changed the record in both directions. Arsenic, a markedly raised calcium, a below-range cysteine and a raised DMG had all been flagged by the labs and never carried forward; dopamine, serotonin and B6 had been carried forward as low and were, in fact, within range. Both corrections are published on this page. Working notes drift from source data over a long case — that is an argument for going back to the reports, not for trusting the summary.

This Was Their Starting Point

A whole person in there — and no way out.

Five years old · a handful of single words · no sentences at all
Couldn't ask for anything — every need was a guessing game
Understanding running ahead of speech — taking far more in than she could give back
Eye contact limited · engagement fleeting
Finger-flicking and repetitive movements through the day
Emotional meltdowns — with no words to head them off
Sleep unreliable, and a household running on the consequences
Stiffness in her body — noticed properly only once it started to go
A mother doing everything asked of her — and wanting one thing to move

This case study is shared with her mother's permission and at her explicit request for privacy. The child's name, location and any identifying detail are withheld. It is unfinished. It runs alongside her ABA therapy, her GP and her school, none of which stopped. The gains are real, hard-won over two and a half years, and part of an arc still unfolding.

"Our journey with Paul began two years ago when our daughter was five and non-verbal. At that time, she was only using a few words and struggled to communicate her needs or form sentences. Following an initial assessment and a tailored plan, we started to notice gradual but meaningful improvements. Within a few months, her speech became clearer and her vocabulary began to expand. We also saw positive changes in her attention and overall behaviour. Over the last two years, she has continued to make steady progress. She is now able to form sentences, express her needs more confidently, and engage in back-and-forth communication. Her behaviour has also become much calmer and more settled. We are very happy with the progress she has made and remain grateful for the ongoing support and guidance."

— Parent of a young client · Autism · Speech & Language

Background & Story

She wasn't looking for a miracle.
She was looking for one thing to move.

Before any clinical detail: this is a mother who had been guessing at her own daughter for five years, and a little girl with a great deal to say and no way to say it.

You have a five-year-old and she has a few words. Not a few sentences — a few words. She cannot tell you she is hungry, or that her stomach hurts, or that the room is too loud. So you learn to read her instead: the way she stands, what she pushes away, how the crying starts. You get good at it. You also know, every single day, that you are guessing. And you can see — anyone close to her can see — that she is taking in far more than she can give back. The understanding is in there. It has nowhere to go.

She had a diagnosis. She had ABA therapy, and it was working within its remit. Her mother was doing everything that had been asked of her and more, and what she kept running into was that nobody was looking at the whole child — at the body underneath the diagnosis. The gut. The nutrition. The immune picture. Whether any of that was contributing to a nervous system that couldn't settle and a language pathway that wouldn't open. Those questions have answers, and they are investigable. They just weren't being asked.

So in January 2024, she came in with two words written at the top of the form: autism, speech delay. And a set of goals that were, frankly, modest. Get the gluten and dairy out. Run some tests. Look at the methylation. See if any of it moves. She was not expecting a transformation. She wanted somebody to look properly, and to be honest with her about what they found.

The Pattern

This was not a mystery. It was a clear diagnosis — with a body underneath it that nobody had examined, because nobody's remit required them to.

Her brain was not simply failing to develop. It appeared to be developing under load — with an immune system activated inside the central nervous system, a gut ecosystem generating inflammation and feeding it upward, a methylation pathway short of what a language-building brain draws on, and a heavy-metal burden sitting across the whole picture. Autism set the terrain. It did not have to have the final word on how much of that load she carried while she tried to learn to speak.

The Clinical Lens

Two symptom clusters.
Two different drivers.

The single most useful decision in this case was refusing to read her presentation as one problem. The stimming and the hyperactivity behaved one way — they improved when immune and viral load was addressed, and returned when that work stopped. The speech and comprehension delay behaved differently — it moved slowly, cumulatively, alongside the methylation and developmental work. Same child, same file, two separate threads. Pull them apart and each one tells you what it needs.

Root Causes Uncovered

What four panels found underneath the diagnosis.

Four organisms overgrown, and the good ones eight-fold down

The stool panel returned four organisms overgrown: enterohaemorrhagic E. coli at forty times its threshold, Streptococcus species at twenty-three times, Enterococcus faecalis at five times, and Staphylococcus aureus at three times. Against that, Bacteroidetes — a dominant beneficial phylum — measured eight-fold below its lower limit. Secretory IgA was raised at 2,789 µg/g and calprotectin at 222 µg/g: the gut immune system was engaged, and the gut lining was inflamed. Firmicutes, contrary to the working note, measured within range.

What this meant day to day: a gut that was generating inflammatory signalling continuously and sending it upward, in a child whose brain was already carrying more than its share.

Yeast overgrowth — and depleted neurotransmitters

Of seventy-seven markers on the organic acids test, exactly two flagged. Arabinose at 88 against a ceiling of 56 — a yeast overgrowth metabolite. And vitamin C at 0.85 against a floor of 10: not low, effectively absent — twelve-fold below the bottom of the range, and the most depleted single marker across all four panels. Quinolinic acid, a neuro-inflammatory metabolite, sat in the upper half of its range.

The correction that matters: the working notes carried dopamine, serotonin and B6 as low for two and a half years. The panel does not support that — all three metabolites measured within range. The real findings were narrower and, in the case of the vitamin C, more striking.

A methylation pathway under strain

The genomics were the finding. COMT V158M A/A — homozygous variant, meaning dopamine clears slowly. MTRR A66G G/G — homozygous variant, meaning B12 recycling is impaired. MTHFR C677T heterozygous, downregulating folate metabolism. On the biochemistry, glutathione measured 640 against a floor of 669 and its precursor cysteine 231 against a floor of 271 — both below range. Methionine sat exactly on the reference floor at 23. Homocysteine and the methylation index were unremarkable.

What this meant day to day: the two pathways a brain leans on hardest to build language were both genetically downregulated, and the antioxidant system meant to handle her metal burden was running below its floor. Reference ranges on this panel are adult-derived — paediatric ranges are not established — which is stated here rather than glossed.

A raised heavy-metal burden

Hair analysis flagged four toxic metals, not three: lead at 1.7 µg/g (limit 1.0), mercury at 0.63 (limit 0.40), antimony at 0.11 (limit 0.066) and arsenic at 0.11 (limit 0.080) — arsenic having been flagged by the laboratory and never carried into the working notes. The minerals were not, as recorded, "quite good": calcium ran at 725 µg/g against a ceiling of 500 while magnesium sat below range at 14, giving a calcium-to-magnesium ratio of 51.8 against a limit of 30. Lead and mercury are established developmental neurotoxicants; the concern is cumulative burden in a developing nervous system, not acute poisoning.

What this meant day to day: four metals to clear, the mineral that buffers the nervous system below range, and the antioxidant meant to do the clearing measured under its floor. Burden up, capacity down.

An immune picture that framed a PANS/PANDAS consideration

Streptococcus species at 2.27e4 against a threshold of 1.00e3 and Staphylococcus aureus at 1.45e3 against 5.00e2, taken together with a symptom pattern that visibly fluctuated with antimicrobial and antiviral work, framed a PANS/PANDAS-type consideration — a recognised paediatric picture in which immune activation following infection drives neuropsychiatric and movement symptoms. This was held as a clinical consideration informing the work, not as a diagnosis; diagnosis sits with her medical team.

What this meant day to day: the stimming was not simply "what she does." It was tracking something, and that something was addressable.

The Clinical Pattern

"This is the pattern I see repeatedly in children with autism and significant speech delay: not one broken system, but four loads stacked on a nervous system that is trying to develop underneath them. You do not remove autism by clearing the load. You remove the load, and you find out how much of what you were looking at was the load."

Is this your child?

If nobody has ever examined the body underneath your child's diagnosis — that is where this starts.

Book a Clarity Call →

Tests Commissioned

Four panels. One connected picture.

Organic Acids · Mosaic Diagnostics

Urine · 77 markers · collected Feb 2024

Ordered to establish whether yeast or bacterial overgrowth was interfering with the neurotransmitter pathways underpinning behaviour, attention and verbal skills. Two markers flagged.

GI-MAP · Diagnostic Solutions

Stool qPCR · pathogens, phyla, SIgA, calprotectin · collected Feb 2024

Ordered to map the gut ecosystem and quantify inflammation and immune engagement — the suspected upstream driver. Six markers flagged high, one low.

Toxic & Essential Elements · Doctor’s Data

Hair · ICP/MS · 39 elements + 5 ratios · collected Apr 2024

Ordered to assess cumulative toxic-metal burden and mineral status in a developing nervous system. Four metals flagged high. Hair reflects the preceding three to six months.

Methylation Panel + Genomics · Genova

Plasma & buccal · 18 biochemical markers + 10 SNPs · collected Mar 2024

Ordered because speech and language development draws heavily on folate and methylation — and because these pathways determine how well the body clears both neurotransmitters and metals. Adult reference ranges; paediatric not established.

Repeat HTMA

Hair · re-baseline metals, copper:zinc ratio

Being arranged at the two-and-a-half-year point to re-baseline lead, mercury and antimony after the detoxification work, and to assess the copper:zinc ratio relevant to the attention picture.

Not Yet Run

Repeat stool · repeat organic acids

Both proposed and both still outstanding. This case is published with that gap stated rather than hidden: the original panels have not yet been repeated, so the biochemical picture reported here is the baseline one.

Functional Testing Findings

What the panels actually said — and what they didn't.

Read this before the results

Four panels, 230-plus markers, four different laboratories. What follows is the actual reported values against the actual printed reference ranges — including four findings that were flagged by the laboratory and did not make it into the clinical working notes, and three that the working notes carried as abnormal and which the panels do not support. Both directions are published here. A case study that only shows the findings that fit the story is not evidence of anything.

Within reference range

Below range · depleted

Above range · elevated

Her result

The root of it: a gut with four organisms overgrown and a lining that was measurably inflamed.

Zone 1 · GI-MAP Stool Analysis · Collected February 2024

The Root of Everything: What the Gut Was Actually Doing

Enterohaemorrhagic E. coli

ELEVATED

3.97e4gEq/g

Reference: < 1000 gEq/g · log scale — A pathogenic strain — 40× the reporting threshold

Streptococcus spp.

ELEVATED

2.27e4gEq/g

Reference: < 1000 gEq/g · log scale — The finding that framed the PANS/PANDAS consideration

Enterococcus faecalis

ELEVATED

5.10e4gEq/g

Reference: < 10000 gEq/g · log scale — Opportunistic overgrowth

Staphylococcus aureus

ELEVATED

1.45e3gEq/g

Reference: < 500 gEq/g · log scale — Opportunistic overgrowth

Bacteroidetes

DEPLETED

1.08e11gEq/g

Reference: 8.6e+11 – 3.3e+12 gEq/g · log scale — A dominant beneficial phylum — 8× below the lower limit

Firmicutes

IN RANGE

7.15e10gEq/g

Reference: 5.7e+10 – 3e+11 gEq/g · log scale — The other dominant phylum — within range, contrary to the working note

Secretory IgA

ELEVATED

2789µg/g

Reference: 510 – 2010 µg/g — Gut immune activation

Calprotectin

ELEVATED

222µg/g

Reference: < 173 µg/g — Direct marker of intestinal inflammation

Clinical translation: four opportunists overgrown, the dominant beneficial phylum eight-fold depleted, and both the gut immune system and the gut lining measurably inflamed. Note the honest correction: Firmicutes measured within range — the working note carried it as low, and it was not. No Candida was detected at all, no parasite exceeded its reference range — Dientamoeba fragilis was quantified at 5.69e3 against a threshold of 1.00e5 and left alone — and every H. pylori virulence factor returned negative.

Zone 2 · Organic Acids · Urine · Collected February 2024

The Yeast Signal — and the One Nutrient That Was Truly Empty

Arabinose

ELEVATED

88mmol/mol cr

Reference: < 56 mmol/mol cr — Yeast overgrowth metabolite

Ascorbic acid (Vitamin C)

DEPLETED

0.85mmol/mol cr

Reference: 10 – 200 mmol/mol cr — 12× below the lower limit — the single most depleted marker on the panel

Quinolinic acid

IN RANGE

4.6mmol/mol cr

Reference: 0.63 – 6.7 mmol/mol cr — Neuro-inflammatory tryptophan metabolite — upper half of range

Homovanillic acid (HVA)

IN RANGE

3.7mmol/mol cr

Reference: < 14 mmol/mol cr — Dopamine metabolite — in range, contrary to the working note

5-HIAA

IN RANGE

2.3mmol/mol cr

Reference: < 7.7 mmol/mol cr — Serotonin metabolite — in range, contrary to the working note

Pyridoxic acid (B6)

IN RANGE

4.1mmol/mol cr

Reference: < 59 mmol/mol cr — B6 marker — in range, contrary to the working note

Pyroglutamic acid

IN RANGE

45mmol/mol cr

Reference: 7 – 63 mmol/mol cr — Glutathione marker on this panel — in range

Clinical translation — and a correction worth making plainly: of 77 markers, only two flagged. Arabinose elevated, and vitamin C almost absent. The working note carried dopamine, serotonin and B6 as "low" — the panel does not support that. Their metabolites sat comfortably within range. What was real was the yeast signal, a profoundly depleted antioxidant, and a neuro-inflammatory marker sitting in the upper half of its range.

The load underneath: four metals raised, and a detoxification system already short of its main tool.

Zone 3 · Toxic & Essential Elements · Hair · Collected April 2024

The Load She Was Carrying While She Learned to Speak

Lead (Pb)

ELEVATED

1.7µg/g

Reference: < 1 µg/g — Established developmental neurotoxicant

Mercury (Hg)

ELEVATED

0.63µg/g

Reference: < 0.4 µg/g — Established developmental neurotoxicant

Antimony (Sb)

ELEVATED

0.11µg/g

Reference: < 0.066 µg/g — Cumulative environmental exposure

Arsenic (As)

ELEVATED

0.11µg/g

Reference: < 0.08 µg/g — Flagged high — and absent from the working note

Calcium (Ca)

ELEVATED

725µg/g

Reference: 140 – 500 µg/g — Markedly high — the working note recorded minerals as "quite good"

Magnesium (Mg)

DEPLETED

14µg/g

Reference: 15 – 45 µg/g — Below range — nervous-system regulation and detoxification

Ca/Mg ratio

ELEVATED

51.8ratio

Reference: 4 – 30 ratio — 73% above the top of the reference range

Zinc (Zn)

IN RANGE

110µg/g

Reference: 100 – 190 µg/g — Bottom of range — relevant to the later attention picture

Clinical translation: four toxic metals flagged high, not three — arsenic was on the report and did not make it into the working note. And the mineral picture was not "quite good": calcium ran at 145% of the upper limit against magnesium below range, producing a calcium-to-magnesium ratio of 51.8 against a ceiling of 30. Burden up, and the minerals that buffer it out of balance — in a child whose glutathione separately measured below its floor. And the picture is broader than even the panel rows above: sodium, potassium and rubidium also flagged high, molybdenum, phosphorus and zirconium low. Six further flags, none of which reached the working notes. The mineral argument is stronger than the notes ever recorded.

Zone 4 · Methylation Panel · Plasma & Buccal · Collected March 2024

The Pathway Language Is Built On

Glutathione

DEPLETED

640µmol/L

Reference: ≥ 669 µmol/L (floor only — no upper bound printed) — The body’s principal antioxidant, below the reference floor

Cyst(e)ine

DEPLETED

231µmol/L

Reference: 271 – 392 µmol/L — Glutathione precursor — below range, and absent from the working note

Methionine

IN RANGE

23µmol/L

Reference: 23 – 38 µmol/L — Sitting exactly on the reference floor — the basis for protein at every meal

Dimethylglycine (DMG)

ELEVATED

7µmol/L

Reference: 1.6 – 5 µmol/L — 40% above range — absent from the working note

Methylation Index (SAM/SAH)

IN RANGE

2.6ratio

Reference: 2.2 – 6.4 ratio — In range, lower half

Homocysteine

IN RANGE

5µmol/L

Reference: 3.7 – 10.4 µmol/L — In range — no elevation to explain the picture

Clinical translation: glutathione and its precursor cysteine both below range, methionine sitting exactly on the floor, and DMG raised — a pattern consistent with a methylation and antioxidant system working at its limit rather than one that has failed. Two caveats stated plainly: the reference ranges on this panel are adult-derived — paediatric ranges are not established — and homocysteine and the methylation index were both unremarkable. The genetics below carried more weight here than the biochemistry did.

Zone 4b · Methylation Genomics · Buccal

The Genetics That Carried the Weight

Gene / SNP

Genotype

Impact

COMT V158M (rs4680)

A/A homozygous

Downregulation — slower dopamine clearance

MTRR A66G (rs1801394)

G/G homozygous

Downregulation — B12 recycling impaired

MTHFR C677T (rs1801133)

C/T heterozygous

Downregulation — folate metabolism

MAT1A (rs3851059)

G/A heterozygous

Downregulation

MTHFR A1298C · SHMT1 · CBS · BHMT · GNMT · MTR

No downregulation

Wild type, silent, or upregulating

Clinical translation: this is where the case actually sits. Two homozygous variants — COMT and MTRR — plus a heterozygous MTHFR C677T. COMT A/A means dopamine clears slowly, which fits a picture of neuro-excitation, meltdowns and difficulty settling. MTRR G/G means B12 recycling is impaired, and MTHFR C677T means folate metabolism is downregulated: together, the two pathways a brain building language leans on hardest. This is why folinic acid and methyl B12 were in the plan from the first appointment. Variants like these are common in the general population and are not diagnostic of autism — they describe how a pathway behaves under load.

How It All Connected

Root Trigger

Gut dysbiosis
& yeast overgrowth

→

Cascade

Gut inflammation
SIgA · calprotectin ↑

→

Amplifier
COMT + MTRR variants
+ 4 raised metals

→

Consequence

Neuro-immune
activation in the CNS

→

Symptom Pattern

Stimming & meltdowns
· speech delay

Read forwards it explains the presentation. Read backwards it gives you the order of work: clear the load, calm the activation, support the pathway, build the foundation. That sequence is the entire protocol on this page.

Timeline of the Journey

Two and a half years — and no plateau.

The Arc at a Glance

Thirty months · six phases · silence to sentences

Reported trajectory · not a measured score

Milestones recorded at follow-up

The curve above plots the milestones recorded in her clinical notes at each follow-up. It is a representation of a reported trajectory — there is no underlying test score, and none is implied.

JAN
24

Phase 1 — January 2024 · Foundations & Investigation

Map everything. Change the food. Start the folate.

Full history taken across diet, infections, toxins, trauma, dentition and environment. Four panels commissioned. Diet moved off gluten and dairy toward a whole-food, protein-forward framework — protein at the centre of every meal, driven directly by methionine sitting on the reference floor. Foundational support introduced gently, with folinic acid included from day one specifically for the speech picture. ABA continued throughout.

MAR
24

Phase 2 — March 2024 · Results & the First Signal

The picture lands — and her mother notices something.

All four panels reviewed together: arabinose elevated, four organisms overgrown, calprotectin and secretory IgA raised, COMT A/A and MTRR G/G homozygous, glutathione below its floor. And the first lived change, in her mother's words: "Interacting, listening more." The speech itself hadn't arrived. But something had. Her note that month was three words long: "Def changes." Gut and methylation work began in earnest.

MAY
24

Phase 3 — May to July 2024 · The First Real Shift

Speaking more. Looking at people. Flicking less.

The month the picture visibly moved on several fronts at once: "Speaking more and comprehension increasing." "Eye contact is better." "Finger flicking is much reduced." More socialising. More agile — the stiffness in her body only obvious now it was going. By July: "A lot calmer. Smiling in the morning." Processing was still slow and she wasn't writing. Both were recorded honestly and left as open problems.

NOV
24

Phase 4 — November 2024 · Words Start Joining Up

Ten months in: connecting words.

"Connecting words now. Better understanding. Responding with signs." For a child who arrived with single words and nothing else, joining two together is the structural beginning of language. Not a cure, not a leap — a foundation. The hand-flapping persisted and was documented as persisting. Metals and detoxification support continued; folate was adjusted.

FEB
25

Phase 5 — 2025 · The Grinding Middle

Progress continues. So does the stimming.

The least glamorous and most honest year of the file. "Improvements continue" and "sleep improved" — alongside "finger flapping remains — the same as before" and "emotional meltdown — more the same." Some things moved; some didn't. A month of antiviral work was trialled, and the stimming categorically improved on it — the single most informative observation in the case. Two additions, lithium and a GABA support, were introduced and then withdrawn when they didn't earn their place. An antifungal course began, pulsed rather than continuous.

JUN
26

Phase 6 — 2026 · Sentences, Sleep & a Cricket Pitch

Two and a half years in: she talks back.

Full sentences. Back-and-forth conversation. Telling her mother what she needs, with confidence. Sleeping naturally in 30–40 minutes — melatonin stopped entirely, deliberately, to protect the dopamine needed for focus. Calmer in the mornings, willing to sit and study. Her school independently reports a sustained year-long upward trajectory. And on a cricket pitch, she hit six balls cleanly and her coach pulled her mother aside to tell her to keep doing whatever she was doing. The programme continues; the neuro-immune phase is where it goes next.

Protocol Overview

Three pillars.
Built over years, not weeks.

Sequence carried this case. Diet and gut foundations first. Methylation and neurotransmitter support alongside — from the first appointment, because language development would not wait. The load-clearing and neuro-immune work layered on top, only when the groundwork underneath could take the weight, and never more than one change at a time. Brands and doses are specific to this child and stay in her file; publishing them would invite people to copy a protocol built for one girl’s biology.

What We Deliberately Stopped or Never Started

In a child, what you take away is as clinical a decision as what you add. Pill burden is not an inconvenience — it is a variable that determines whether any of it gets taken at all.

Two additions were trialled and withdrawn when they did not clearly earn their place. Melatonin, which had genuinely helped her sleep, was first restricted to four nights a week and then stopped altogether — partly because sleep was holding on its own, and partly because it works against the dopamine that her attention depends on. One antimicrobial was deliberately finished and not repeated. A prebiotic she couldn't tolerate in powder form was changed rather than pushed. And the antifungal work was pulsed, not run continuously, because yeast adapts to what never stops. Across the file, the protocol gets pruned about as often as it grows.

Diet & Gut Foundation

Gluten and dairy removed and held — the original goal her mother arrived with, sustained across two and a half years
A whole-food, protein-forward framework — protein at the centre of every meal, driven directly by methionine sitting exactly on the reference floor
Gut barrier and repair support — targeting the raised calprotectin and the depleted beneficial phyla seen on the stool panel
Beneficial bacteria rebuilding, and a prebiotic reformulated when the original form wasn't tolerated

Methylation & Neurotransmitter Support

Active folate (folinic acid) from the first appointment for the speech pathway — titrated upward over the programme as her language developed
Methyl B12 for the flagged MTRR requirement, titrated slowly with a clear stop rule if anxiety appeared
Vitamin C — measured at 0.85 against a floor of 10, the most depleted marker across all four panels, and a direct input to both antioxidant capacity and neurotransmitter synthesis
Glutathione support, cycled rather than continuous — rebuilding the measured deficit (640 against a floor of 669) that four raised metals were drawing on

Load Clearing & Neuro-Immune Layer

Staged antimicrobial and antifungal work — pulsed on alternating weeks across a four-month course to prevent yeast adapting
Gentle, gradual heavy-metal detoxification support — never forced, with a repeat panel to decide what, if anything, comes next
Antiviral work — the intervention the stimming visibly responded to, and the observation that shaped the current phase
Neuro-immune calming and a daily fifteen-minute retained-reflex movement routine at home — the current phase, alongside her ABA

What Actually Moved the Needle

Five decisions.
Only one of them was a supplement.

Separating the two symptom clusters — and refusing to read them as one problem

This is the decision the whole case turns on. The stimming and the speech delay looked like one presentation and behaved like two. When a month of antiviral work visibly reduced the finger-flicking — and it returned when that work stopped — the file effectively answered its own question: Cluster A was immune-driven and responsive; Cluster B needed the methylation and folate lever instead. Had both been read simply as "autism", the plan would have chased the wrong driver for two years. → Two clusters, two mechanisms, two levers — and the evidence for the split came from her own response, not from a textbook.

Backing folate from the first appointment — and staying with it for two and a half years

Folinic acid was in the plan on day one, written against a single line: for speech. The genomics then corroborated it — MTHFR C677T downregulating folate metabolism, MTRR G/G homozygous impairing B12 recycling, methionine sitting exactly on the reference floor. There is randomised, placebo-controlled trial evidence for folinic acid and verbal communication in autism, and the dose was titrated upward across the programme as her language built. Of everything in this file, folinic acid is the intervention with the most direct evidence behind it — and it was started before a single result came back, then held through every phase for thirty months. → The pathway language is built on was supported continuously, from the first month to the current one.

Clearing the gut load first — because inflammation doesn't stay in the gut

Overgrown opportunists, depleted beneficial phyla, raised SIgA and calprotectin. Rebuilding the barrier and the ecosystem came before any aggressive clearance, and the antifungal work was pulsed rather than continuous. → Lowering the inflammatory signal reaching the brain reduced the load she was developing under.

Rebuilding detoxification capacity before pushing on the metals

Four metals raised — lead, mercury, antimony and arsenic — against glutathione at 640 with a floor of 669, cysteine below range, and magnesium under range while calcium ran at 145% of its ceiling. Forcing clearance in a five-year-old with no antioxidant reserve is the wrong order. Glutathione and minerals were rebuilt first, metal support was gentle and gradual, and a repeat panel now decides what comes next. → Capacity before challenge — the sequence that respects how small she was.

Taking things away — including the one that worked

Melatonin helped her sleep, and it was still stopped, because it works against the dopamine her attention needs and her sleep was holding without it. Two other additions were trialled and withdrawn. In a child on a long protocol, every unnecessary item costs compliance — and compliance is what a two-and-a-half-year programme actually runs on. → A protocol that gets pruned is a protocol a family can still be following two years later.

Measurable Results & Lived Change

What changed — in two and a half years.

A few single words

Full sentences · two-way conversation

Communication

Couldn't ask for anything

Expresses her needs with confidence

Independence

Melatonin needed

Asleep naturally in 30–40 min

Sleep

Meltdowns · unsettled

"Much calmer and more settled"

Regulation

The Real Win — In Context

A mother who spent five years guessing at what her daughter needed now gets told. That is the result. Everything else on this page is scaffolding underneath it.

These changes are described by her mother, corroborated independently by her school, and observed at clinical follow-up over thirty months. No formal developmental scoring was carried out by this clinic — no ATEC, no CARS, no standardised language assessment — and none is claimed. Her school reports a sustained upward trajectory over the past year. The most clinically meaningful feature of this case is not the speed of any single change but the absence of a plateau across two and a half years.

Every child is different. What happened here belongs to one girl’s biology, history and circumstances — alongside two and a half years of consistency from a mother holding a demanding protocol through ordinary life. It is not a prediction of results for any other child, and it does not describe a change in her diagnosis.

Before vs After

The shift — as her mother lived it.

Before — January 2024

A handful of words · no sentences

Five years old and effectively without language

Guessing at her own child

Every need worked out by elimination

Eye contact fleeting

Engagement hard to hold

Meltdowns · unsettled · poor sleep

A household running on the consequences

Hoping something might move

Modest goals, written on a form

After — 2.5 years

"She is now able to form sentences"

And to argue her corner in them

She tells her mother what she needs

The guessing is over

Six balls hit cleanly · coach took notice

Coordination, reflexes and focus, in public

"Much calmer and more settled" · sleeps naturally

Melatonin no longer needed at all

A year-long upward trajectory — per her school

Corroborated outside the family, and still climbing

The Honest Ledger

What moved — and what is still on the list.

Moved

✓

Expressive language

A few words → full sentences and two-way conversation

✓

Comprehension & attention

Willing to sit and study; school reports sustained gains

✓

Eye contact & social engagement

Noted improving from month three onward

✓

Sleep

Natural onset in 30–40 min · melatonin stopped entirely

✓

Regulation & mood

"Much calmer and more settled"; calmer in the mornings

✓

Coordination & physical stiffness

Stiffness resolved early; cricket coach took notice at year two

Still Open

—

Finger-flapping / stimming

Improved on antiviral work, returned when it stopped. Persists. The target of the current phase.

—

Concentration — a possible attention picture

Raised by her school. Formal ADHD assessment now being pursued through the proper channels.

—

Repeat testing

Stool and organic acids proposed but not yet repeated. Hair analysis now being arranged.

—

Emotional meltdowns

Reduced overall, but recorded as "more the same" through much of 2025.

—

Writing

Flagged as poor in 2024 and not since resolved.

Who Else This Pattern Fits

This may reflect your child's situation if…

Your child has autism with significant speech or language delay

They understand far more than they can say — the comprehension is visibly ahead of the speech

You are guessing at what they need, every day, because they cannot tell you

Repetitive movements or stimming seem to change with illness, antibiotics or certain foods

There are gut symptoms alongside the developmental picture — or there have been for years

Sleep is unreliable and the whole household is running on the consequences

Therapy is in place and working, but nobody has looked at the body underneath the diagnosis

You want the gut, immune and methylation picture measured rather than assumed

You want support that runs alongside your ABA, GP and school team — not instead of them

You are prepared for this to take years, and you want somebody honest with you throughout

If several of these fit — this is worth a conversation.

Clinical & Life Lessons

What this case teaches.

One diagnosis can contain two different problems

The stimming and the speech delay both sat under the word "autism" and had almost nothing in common mechanically. One responded to immune and antiviral work; the other moved with methylation and folate support over years. Separating them was the single most useful clinical act in this file — and the evidence for the split came from watching how she responded, not from a framework.

In development, trajectory beats speed

Nothing here happened fast. Interaction at two months, clearer speech at three, joined words at ten, sentences across the second year. What made it credible was not the pace but the absence of a plateau across thirty months — corroborated independently by her school. In a developmental picture, a line that keeps rising is worth more than any single dramatic month.

A child's response to what you give them is itself clinical information

The stimming improving on antiviral work — and returning when it stopped — told us more than any panel did. It confirmed an immune driver behind a symptom that is usually written off as simply "part of autism," and it set the direction of the entire current phase. Watch what the child does with what you give them. That is data.

Capacity before challenge — always, in a small child

Four toxic metals raised, and glutathione measured below its floor. The instinct is to start clearing. The right order was to rebuild the antioxidant and mineral capacity first, then support clearance gently, then re-test before deciding anything further. Forcing a detoxification pathway that has nothing to detoxify with is not treatment. It is just load.

Taking things away is clinical work too

Melatonin was helping her sleep and it was still withdrawn, because it works against the dopamine her attention needs. Two other additions were trialled and stopped. Over a two-and-a-half-year protocol, pill burden decides compliance and compliance decides everything. A shorter protocol that gets taken beats a comprehensive one that doesn't.

Thirty months is the finding

There is no month in this file you could point to and call the breakthrough. There is a two-month note reading "def changes", a long flat year reading "the same as before", and a girl who, somewhere across all of it, started talking. Work like this is not delivered — it is accumulated, in a household, by a mother, on ordinary Tuesdays, long after the interesting part is over. That is the actual mechanism, and it is the one nobody advertises.

A note from the practitioner

The moment I keep coming back to isn't a lab result. It's the cricket. A child going up and hitting six balls cleanly, and the coach pulling her mother aside to say: keep doing whatever you're doing. Nobody at that pitch knew anything about her file. They were just watching a girl who could do something — and that is her vestibular system and her reflexes maturing in real time, in public, in front of people who had no reason to be kind about it.

What strikes me looking back through thirty months of notes is how unglamorous the middle was. There is a whole year in this file where the entries read "progress continues" and "the same as before" in the same paragraph. That is what this work actually looks like. Not a breakthrough — a slow, stubborn accumulation, held in place by a mother who kept going when there was nothing dramatic to show for it.

So let me be exact about what I think happened, because she deserves better than a tidy story. Her autism is unchanged and was never what I was working on. What I found were four things that were measurably wrong — an inflamed gut, a yeast marker, four raised metals, two downregulated methylation genes — and I spent thirty months lifting them, one at a time, off a brain that was trying to build language underneath them. Whether that is why she speaks now, I cannot prove. I did not re-run her panels, her ABA ran throughout, and she was five and growing. What I can say is that the load came off and she moved, and that she has not stopped moving since.

To her mother: you spent five years guessing at what she needed. She tells you now. Whatever else is still on the list, that happened — and a very large part of why it happened is you.

— Paul Foley, BANT-registered Nutritional Therapist

Frequently Asked Questions

Autism, speech delay & the gut-brain picture — direct answers.

My child is non-verbal — is there any point investigating their gut?

Functional medicine does not diagnose, treat or cure autism or speech delay. It investigates the gut, immune, nutritional and methylation drivers that influence how a child's body is operating alongside their neurodevelopmental profile, and builds a protocol to support the body's own regulatory systems. In this case the work addressed yeast and bacterial overgrowth, a compromised methylation pathway, a raised heavy-metal burden and an activated neuro-immune picture. It ran alongside the child's ongoing ABA therapy, GP care and school support throughout — not instead of them. Over two and a half years her expressive language moved from a handful of single words to full sentences and back-and-forth conversation.

What is the neuro-immune model of autism?

The neuro-immune model describes an over-active immune response within the central nervous system, layered on top of contributing factors such as gut dysbiosis, impaired methylation and a toxic-metal burden. In this case the working model held that the repetitive movements and hyperactivity tracked with neuro-excitation and immune activation, while the speech and comprehension delay tracked with the developmental and methylation picture. This is a clinical working model that guides which drivers are investigated and supported. It is not a diagnosis, and it does not replace neurodevelopmental assessment by a paediatric team.

How many findings does a functional panel actually return? (In this case, fewer than you would think)

Fewer than the marketing implies, and that is the point. Four panels were run here — organic acids, GI-MAP stool, hair elements and a methylation panel with genomics — totalling roughly 230 markers. The organic acids panel flagged two of seventy-seven: a yeast metabolite, and a vitamin C that was effectively absent. Everything else was normal. A panel earns its cost as much by what it rules out as by what it finds, and a page listing twenty dramatic abnormalities should make you suspicious rather than impressed. Re-reading these raw reports against two and a half years of clinical notes also corrected the record in both directions — findings the notes had missed, and findings the notes had invented.

What does a COMT variant mean for a child with autism?

COMT is an enzyme that clears dopamine and other catecholamines from the synapse. A double variant is associated with slower clearance, which can mean neurotransmitters linger longer — relevant to a picture of neuro-excitation, emotional meltdowns and difficulty settling. In this case the COMT variant was A/A homozygous, sitting alongside an MTRR A66G G/G homozygous variant impairing B12 recycling and a heterozygous MTHFR C677T downregulating folate metabolism, with glutathione and cysteine both measuring below range. Genetic variants are not destiny: they describe how a pathway is likely to behave under load, which informs what nutritional support that pathway may benefit from. They are common in the general population and are not diagnostic of autism.

Why is folinic acid used for speech delay in autism?

Folinic acid is the active, reduced form of folate. A randomised, double-blind, placebo-controlled trial published in Molecular Psychiatry in 2018 reported improvements in verbal communication in children with autism and language impairment given high-dose folinic acid. In this case folinic acid was included from the first appointment specifically for the speech picture, alongside methyl B12 for the flagged methylation pathway, and was gradually titrated upward over the programme as her language developed. Research describes what happened across a population — it does not predict the outcome for any individual child.

Why were antifungals pulsed rather than taken continuously?

Yeast and mould are highly adaptable and can become tolerant to an antifungal agent that is used continuously. Pulsing — alternating agents on a weekly cycle rather than running one without interruption — is used to reduce that adaptation. In this case arabinose, a yeast overgrowth metabolite, measured 88 against a ceiling of 56 on the organic acids test — while the stool panel detected no Candida at all, so the picture rested on the urinary marker rather than a cultured organism. A pulsed regimen alternated two different antifungal approaches on alternating weeks across a four-month course. Any antifungal work in a child should be introduced slowly and monitored, as clearing organisms too quickly can produce a temporary worsening of symptoms.

Should I expect this to take months or years?

Years. Anyone promising otherwise for a developmental picture is selling something. Her mother reported increased interaction and listening within two months. Clearer speech, better eye contact and markedly reduced finger-flicking were noted at around three months. Connecting words together came at ten months. Full sentences and two-way conversation developed across the second year. The most useful signal was not the speed but the absence of a plateau — a sustained upward trajectory over two and a half years, corroborated by her school.

Where does this sit next to ABA and my GP?

No. This child continued ABA therapy throughout the programme, remained under her GP, and her school remained closely involved. When her school raised concentration concerns and a possible attention-deficit picture, the clinical recommendation was to start the formal assessment process — take up the school psychiatrist's offer of a report and request a GP referral to CAMHS. Nutritional therapy sat alongside that care, investigating the gut, immune, metal and methylation questions a standard appointment has no time to ask. Diagnosis and developmental assessment remain with the medical and educational teams.

The Science Behind This Case

Research informing this approach.

These are the papers that justified the two decisions this case rests on: backing folate from day one, and reading the stimming as immune-driven. Where the evidence is thin, that is said below rather than dressed up. None of it predicts what would happen for any other child.

The evidence behind the folate decision

Frye RE, Slattery J, Delhey L, et al. Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial. Mol Psychiatry. 2018;23(2):247–256. doi:10.1038/mp.2016.168
Ramaekers VT, Rothenberg SP, Sequeira JM, et al. Autoantibodies to folate receptors in the cerebral folate deficiency syndrome. N Engl J Med. 2005;352(19):1985–1991. doi:10.1056/NEJMoa043160

Why the gut was addressed before the brain

Sharon G, Cruz NJ, Kang DW, et al. Human Gut Microbiota from Autism Spectrum Disorder Promote Behavioral Symptoms in Mice. Cell. 2019;177(6):1600–1618. doi:10.1016/j.cell.2019.05.004
Kang DW, Adams JB, Coleman DM, et al. Long-term benefit of Microbiota Transfer Therapy on autism symptoms and gut microbiota. Sci Rep. 2019;9:5821. doi:10.1038/s41598-019-42183-0

What a COMT A/A genotype actually predicts

Tunbridge EM, Harrison PJ, Weinberger DR. Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond. Biol Psychiatry. 2006;60(2):141–151. doi:10.1016/j.biopsych.2005.10.024
Gadow KD, Roohi J, DeVincent CJ, et al. Association of COMT (Val158Met) and BDNF (Val66Met) gene polymorphisms with anxiety, ADHD and tics in children with autism spectrum disorder. J Autism Dev Disord. 2009;39(11):1542–1551. doi:10.1007/s10803-009-0794-4

Why four raised metals mattered in a five-year-old

Grandjean P, Landrigan PJ. Neurobehavioural effects of developmental toxicity. Lancet Neurol. 2014;13(3):330–338. doi:10.1016/S1474-4422(13)70278-3
Rahbar MH, Samms-Vaughan M, Dickerson AS, et al. Blood Lead Concentrations in Jamaican Children with and without Autism Spectrum Disorder. Int J Environ Res Public Health. 2015;12(1):83–105. doi:10.3390/ijerph120100083

Why the stimming was read as immune-driven

Swedo SE, Leckman JF, Rose NR. From Research Subgroup to Clinical Syndrome: Modifying the PANDAS Criteria to Describe PANS (Pediatric Acute-onset Neuropsychiatric Syndrome). Pediatr Therapeut. 2012;2:113. doi:10.4172/2161-0665.1000113
Chang K, Frankovich J, Cooperstock M, et al. Clinical evaluation of youth with pediatric acute-onset neuropsychiatric syndrome (PANS): recommendations from the 2013 PANS Consensus Conference. J Child Adolesc Psychopharmacol. 2015;25(1):3–13. doi:10.1089/cap.2014.0084

Clinical Interpretation & Limitations

What this case does and doesn't show.

Read this section as carefully as the results. A page like this is worth exactly as much as its weakest claim, and the four below are where this case is weakest.

Thirty months is long enough for anything to explain it

The honest problem with a long case is that time itself becomes a rival explanation. Between five and seven, children acquire language. Her ABA ran the entire period. Diet, gut, methylation, metals and antimicrobial phases all overlapped. Nothing on this page can untangle which of those did the work, and the length of the programme — the thing that makes the trajectory persuasive — is precisely what makes the attribution impossible.

The outcomes are described, not scored

The laboratory values on this page are real and sourced from the original reports. The outcomes are not: they are reported by her mother, corroborated by her school, and observed at follow-up. This clinic ran no standardised developmental or language assessment — no ATEC, no CARS. So the biochemistry is measured and the trajectory is described, and those two things should not be read with equal confidence.

She is still autistic

Her diagnosis has not changed and was never the target. No nutritional intervention treats, cures or reverses autism, and nothing here was offered as doing so. What was addressed were four measurable things — an inflamed gut, a yeast marker, four raised metals, a downregulated methylation pathway — that exist in their own right and would be worth correcting in any child who had them.

The baseline was never re-run

This is the gap that bothers me most. Every number on this page is from 2024. The stool and organic acids panels were proposed for repeat and never done, so there is no biochemical evidence that any of the gut or metal work achieved what it set out to. The hair panel is only now being re-run. Two and a half years of protocol, and the honest position is that we cannot show the terrain moved — only that she did.

How we work

Paul Foley is a registered nutritional therapist and functional medicine practitioner. He works with clients — including children — living with complex, chronic and neurodevelopmental conditions, alongside, not instead of, the medical, behavioural and educational care they receive from their GPs, paediatricians, therapy teams and schools.

Nutritional therapy does not diagnose, treat or cure medical conditions. It investigates the nutritional, gut, metabolic and lifestyle drivers that influence how the body operates, and builds personalised protocols to support the body's own regulatory systems. Any changes to prescribed medication, and all decisions about a child's medical care and diagnosis, remain with the treating doctors.

Every child's case is different. Outcomes described on this page reflect the specific circumstances of this individual and are not a prediction of results for any other person.

Registered with BANT · CNHC

Written and reviewed by Paul Foley, BANT-registered Nutritional Therapist · 15+ years clinical experience · pfoleyclinic.com/about

Is Your Child Taking More In Than They Can Give Back?

Somebody should
be listening.

If your child has things to say and no way to say them, the least anyone owes you is a proper look at the body underneath the diagnosis. That is what the first appointment is: an assessment of whether there is anything here worth investigating, and an honest answer if there isn’t. Some families are told there isn’t.

Book a Clarity Call →

PFoley Clinic · Functional Medicine

Autism, Speech Delay & Neuro-Immune Recovery: Functional Medicine Case Study

Somebody shouldbe listening.

Somebody should
be listening.